Source link : https://newshealth.biz/health-news/new-myeloma-bispecific-rivals-car-t-in-early-data/
CHICAGO — Two early-phase clinical trials released data at the American Society of Clinical Oncology (ASCO) 2025 annual meeting that suggest their premise — an elranatamab-based triplet regimen and a new trispecific regimen — shows good potential in multiple myeloma (MM). “It was interesting to see where these new lines of thought will take us […]
The post New Myeloma Bispecific Rivals CAR T in Early Data first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-18 13:10:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8